Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Autor: Hampras, Shalaka S., Sucheston-Campbell, Lara E., Cannioto, Rikki, Chang-Claude, Jenny, Modugno, Francesmary, Dörk, Thilo, Hillemanns, Peter, Preus, Leah, Knutson, Keith L., Wallace, Paul K., Hong, Chi-Chen, Friel, Grace, Davis, Warren, Nesline, Mary, Pearce, Celeste L., Kelemen, Linda E., Goodman, Marc T., Bandera, Elisa V., Terry, Kathryn L., Schoof, Nils, Eng, Kevin H., Clay, Alyssa, Singh, Prashant K., Joseph, Janine M., Aben, Katja K.H., Anton-Culver, Hoda, Antonenkova, Natalia, Baker, Helen, Bean, Yukie, Beckmann, Matthias W., Bisogna, Maria, Bjorge, Line, Bogdanova, Natalia, Brinton, Louise A., Brooks-Wilson, Angela, Bruinsma, Fiona, Butzow, Ralf, Campbell, Ian G., Carty, Karen, Cook, Linda S., Cramer, Daniel W., Cybulski, Cezary, Dansonka-Mieszkowska, Agnieszka, Dennis, Joe, Despierre, Evelyn, Dicks, Ed, Doherty, Jennifer A., du Bois, Andreas, Dürst, Matthias, Easton, Doug, Eccles, Diana, Edwards, Robert P., Ekici, Arif B., Fasching, Peter A., Fridley, Brooke L., Gao, Yu-Tang, Gentry-Maharaj, Aleksandra, Giles, Graham G., Glasspool, Rosalind, Gronwald, Jacek, Harrington, Patricia, Harter, Philipp, Hasmad, Hanis Nazihah, Hein, Alexander, Heitz, Florian, Hildebrandt, Michelle A.T., Hogdall, Claus, Hogdall, Estrid, Hosono, Satoyo, Iversen, Edwin S., Jakubowska, Anna, Jensen, Allan, Ji, Bu-Tian, Karlan, Beth Y., Kellar, Melissa, Kelley, Joseph L., Kiemeney, Lambertus A., Klapdor, Rüdiger, Kolomeyevskaya, Nonna, Krakstad, Camilla, Kjaer, Susanne K., Kruszka, Bridget, Kupryjanczyk, Jolanta, Lambrechts, Diether, Lambrechts, Sandrina, Le, Nhu D., Lee, Alice W., Lele, Shashikant, Leminen, Arto, Lester, Jenny, Levine, Douglas A., Liang, Dong, Lissowska, Jolanta, Liu, Song, Lu, Karen, Lubinski, Jan, Lundvall, Lene, Massuger, Leon F.A.G., Matsuo, Keitaro, McGuire, Valeria, McLaughlin, John R., Mcneish, Iain, Menon, Usha, Moes-Sosnowska, Joanna, Narod, Steven A., Nedergaard, Lotte, Nevalinna, Heli, Nickels, Stefan, Nevanlinna, Heli, Olson, Sara H., Orlow, Irene, Weber, Rachel Palmieri, Paul, James, Pejovic, Tanja, Pelttari, Liisa M., Perkins, Barbara, Permuth-Wey, Jenny, Pike, Malcolm C., Plisiecka-Halasa, Joanna, Poole, Elizabeth M., Risch, Harvey A., Rossing, Mary Anne, Rothstein, Joseph H., Rudolph, Anja, Runnebaum, Ingo B., Rzepecka, Iwona K., Salvesen, Helga B., Schernhammer, Eva, Schmitt, Kristina, Schwaab, Ira, Shu, Xiao-Ou, Shvetsov, Yurii B., Siddiqui, Nadeem, Sieh, Weiva, Song, Honglin, Southey, Melissa C., Tangen, Ingvild L., Teo, Soo-Hwang, Thompson, Pamela J., Timorek, Agnieszka, Tsai, Ya-Yu, Tworoger, Shelley S., Tyrer, Jonathan, van Altena, Anna M., Vergote, Ignace, Vierkant, Robert A., Walsh, Christine, Wang-Gohrke, Shan, Wentzensen, Nicolas, Whittemore, Alice S., Wicklund, Kristine G., Wilkens, Lynne R., Wu, Anna H., Wu, Xifeng, Woo, Yin-Ling, Yang, Hannah, Zheng, Wei, Ziogas, Argyrios, Gayther, Simon A., Ramus, Susan J., Sellers, Thomas A., Schildkraut, Joellen M., Phelan, Catherine M., Berchuck, Andrew, Chenevix-Trench, Georgia, Cunningham, Julie M., Pharoah, Paul P., Ness, Roberta B., Odunsi, Kunle, Goode, Ellen L., Moysich, Kirsten B.

Background: Regulatory T (Treg) cells, a subset of CD4+ T lymphocytes, are mediators of immunosuppression in cancer, and, thus, variants in genes encoding Treg cell immune molecules could be associated with ovarian cancer.\ud Methods: In a population

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4ae7e1dedf5a09ae6395dc007fd45b99
https://eprints.gla.ac.uk/123445/1/123445.pdf

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

Autor: Hampras SS; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Sucheston-Campbell LE; College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA., Cannioto R; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Modugno F; Department of Epidemiology and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA., Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Hillemanns P; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany., Preus L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Knutson KL; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Wallace PK; Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York, USA., Hong CC; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Friel G; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Davis W; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Nesline M; Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Kelemen LE; Alberta Health Services-Cancer Care, Department of Population Health Research, Calgary, Alberta, Canada., Goodman MT; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Terry KL; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Schoof N; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Eng KH; Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York, USA., Clay A; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Singh PK; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Joseph JM; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Aben KK; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., Anton-Culver H; Department of Epidemiology and School of Medicine, University of California Irvine, Irvine, California, USA., Antonenkova N; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus., Baker H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Bean Y; Department of Obstetrics & Gynecology and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bjorge L; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway., Bogdanova N; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada., Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia., Butzow R; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Campbell IG; Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Australia., Carty K; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK., Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA., Cramer DW; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Clinic of Opthalmology, Pomeranian Medical University, Szczecin, Poland., Dansonka-Mieszkowska A; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Dennis J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Despierre E; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium., Dicks E; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Doherty JA; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany., Dürst M; Department of Gynecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany., Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Edwards RP; Department of Obstetrics, Gynecology & Reproductive Sciences and Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Fasching PA; Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA., Fridley BL; Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas, USA,., Gao YT; Shanghai Cancer Institute, Shanghai, China., Gentry-Maharaj A; Institute for Women's Health, Population Health Sciences, University College - London, London, United Kingdom., Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia., Glasspool R; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK., Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Harrington P; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany., Hasmad HN; Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia., Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany., Hildebrandt MA; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hogdall C; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hogdall E; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark., Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina, USA., Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Ji BT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Kellar M; Department of Obstetrics & Gynecology and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Kelley JL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Kiemeney LA; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., Klapdor R; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Kolomeyevskaya N; Division of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Krakstad C; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway., Kjaer SK; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Kruszka B; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Kupryjanczyk J; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium,.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium., Lambrechts S; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium., Le ND; Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada., Lee AW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Lele S; Division of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Leminen A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA., Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Liu S; Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York, USA., Lu K; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Lubinski J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia., Lundvall L; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Massuger LF; Department of Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Matsuo K; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., McGuire V; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, USA., McLaughlin JR; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada., McNeish I; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Menon U; Women's Cancer, UCL EGA Institute for Women's Health, London, UK., Moes-Sosnowska J; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Narod SA; Women's College Research Institute, Toronto, Ontario, Canada., Nedergaard L; Department of Pathology, Rigshospitalet, University of Copenhagen, Denmark., Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Nickels S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA,., Weber RP; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Paul J; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK., Pejovic T; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Perkins B; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Plisiecka-Halasa J; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Poole EM; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA., Rossing MA; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Rothstein JH; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, USA., Rudolph A; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Runnebaum IB; Department of Gynecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany., Rzepecka IK; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Salvesen HB; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway., Schernhammer E; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Schmitt K; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Schwaab I; Institut für Humangenetik Wiesbaden, Wiesbaden, Germany., Shu XO; Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA., Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, Scotland, UK., Sieh W; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, USA., Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia., Tangen IL; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway., Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia,., Thompson PJ; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Timorek A; Department of Obstetrics, Gynecology and Oncology, Warsaw Medical University and Brodnowski Hospital, Warsaw, Poland., Tsai YY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Tworoger SS; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Tyrer J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., van Altena AM; Department of Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Vergote I; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium., Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Wang-Gohrke S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Whittemore AS; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, USA., Wicklund KG; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Woo YL; Department of Obstetrics and Gynaecology, Affiliated with UM Cancer Research Institute, Faculty of Medicine, University of Malaya, Malaysia., Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Zheng W; Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Ziogas A; Department of Epidemiology and School of Medicine, University of California Irvine, Irvine, California, USA., Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Schildkraut JM; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA., Chenevix-Trench G; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; On behalf of the Australian Ovarian Cancer Study Group., Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Pharoah PP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Ness RB; School of Public Health, The University of Texas, Houston, Texas, USA., Odunsi K; Division of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.

Publikováno v: Oncotarget [Oncotarget] 2016 Oct 25; Vol. 7 (43), pp. 69097-69110.